Nutriband Inc (NTRB) Stock Price, Quote & News

Company Profile

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company h...

Industry: Biotechnology

Sector: Healthcare

Phone: 407 377 6695

Website: www.nutriband.com

Address:

121 South Orange Avenue, Suite 1500, Orlando, United States

Pacificstock27 Dec. 7 at 3:55 PM

$NTRB can we have a TGL or SMX type run. Probably not like that . Those were insane. Would love to get at least back to double digits again and test 52 week highs early next year.

0 · Reply

TheRoaringBunny Dec. 5 at 2:41 PM

$DEVS $KITT $NTRB $NXPL $VNDA $NXPL ~0.65 Insane setup: → $13M net cash (75% of $17M mcap) → $55M+ 2025 rev run-rate → <0.4x sales → 13M float shrinking fast Catalysts hitting now: • Huge DevotedDoc multi-state deal → Q4/Q1 rev about to explode • $1.9M buyback raging (no expiration), management scooping 60-70¢ aggressively • ZERO dilution, no debt, no warrants, no ATM — the anti-penny stock • ClearMetrX 4.0 AI platform live → new recurring revenue • Satellite + more gov contracts loading • Nasdaq safe till Apr ’26 (no R/S) Cash-rich 70% grower trading for nothing. Compliance break → violent move to $1.30–$1.40. Screams future acquisition target. Swing the double or HODL the gem. Loading heavy while it’s dumb cheap 🚀

0 · Reply

topstockalerts Dec. 4 at 9:53 PM

After Hours Top Gainers PT2 $NXPL $VNDA $KITT $DEVS $NTRB

0 · Reply

NNTrader Dec. 4 at 6:21 PM

$NTRB bullish

0 · Reply

Covode13 Dec. 4 at 3:12 PM

$NTRB so when are we filing to be approved by FDA? Seems like we are at a stand still and we aren’t hearing anything?

1 · Reply

Covode13 Dec. 2 at 1:45 PM

$NTRB so anything happen at these conferences of the product for FDA approval?

1 · Reply

Covode13 Dec. 1 at 5:09 PM

$CRDL this won’t move until they partner with bigger pharmaceutical companies or when they say they are filing for FDA approval. Time that this will happen or if happens. That’s years away. 2-5 at least. $NTRB filed for approval beginning of the year. They still haven’t been approved yet. So yes we have years and years till then!

1 · Reply

Covode13 Nov. 27 at 4:04 PM

$NTRB

0 · Reply

tallguy777 Nov. 26 at 4:09 PM

$NTRB entire market green, and this turd still remains at the bottom of the bowl?

1 · Reply

NetworkNewsWire Nov. 24 at 8:32 PM

NetworkNewsBreaks – $NTRB Announces Chairman Presentation at NobleCon21 https://ibn.fm/nMjNS

2 · Reply

Market Cap	58.01M
Revenue (ttm)	2.14M
Net Income (ttm)	-10.48M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-489.72%
Debt to Equity Ratio	0.01

Volume	18,600
Avg Vol	32,856
Day's Range	N/A - N/A
Shares Out	12.04M
Stochastic %K	46%
Beta	1.89
Analysts	Sell
Price Target	$15.00